Type 1 Diabetes Screening and Diagnosis

Endocrinol Metab Clin North Am. 2024 Mar;53(1):17-26. doi: 10.1016/j.ecl.2023.09.008. Epub 2023 Oct 17.

Abstract

Those with concerning signs or symptoms should be evaluated for type 1 diabetes (T1D). Those with first-degree relatives with T1D or based on the presence of high-risk genes are at increased risk and benefit from screening. Universal screening should be considered in light of new potential therapies to delay disease progression. Although oral glucose tolerance test is the gold standard for T1D staging, there are multiple tools available when oral glucose tolerance test is not feasible. Risk score calculations increase the ability to predict disease progression. Testing should be repeated when symptoms of overt diabetes mellitus are not present.

Keywords: T1D diagnosis; T1D screening; T1D screening programs; T1D staging and risk of progression.

Publication types

  • Review

MeSH terms

  • Diabetes Mellitus, Type 1* / diagnosis
  • Disease Progression
  • Humans
  • Risk Factors